Logo

Piramal Pharma Share Price

Piramal Pharma (INR)258.25-8   (-3%)

Exchange ScripsBSE543635NSEPPLPHARMAISININE0DK501011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Piramal Pharma Performance

Market performance
Open price265
High267.65
Volumes3750638
Prev Close258.25
Low256.5
Closing date2025-01-01
Historical performance
1 Year High307.90
3 Year High307.90
5 Year High307.90
1 Year Low114.35
3 Year Low61.62
5 Year Low61.62

Piramal Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
0
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1917.22
Dividend Yield
Dividend Yield
N/A

Piramal Pharma Investment Returns

1 Year
86.4%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Piramal Pharma Technicals

IndicatorsValueSignal
5-DMA260.34Bearish
10-DMA259.06Bearish
20-DMA259.11Bearish
50-DMA258.04Bullish
100-DMA234.53Bullish
200-DMA191.31Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1717171717
Foreign Investors---------------
Domestic Investors1717171717
Public Investors359734306381297979292295300589
Government11221

Piramal Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2011225127581641
Operating Profit1371785331225515921
Interest4485344219821634
Depreciation7406676758625450
Profit Before Tax1793-120248509490
Consolidated Net Profit178-186537608350
Adjusted EPS----238

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1322911933118599946
Total Reserves65610558025510746103
Minority Interest------------
Total Non-Current Liabilities29288381202902625604
Total Liabilities152972144365127172107561
Capital Work in Progress5657852967323995
Total Assets152972144365127172107561

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities10045483976645976
Cash Flow from Investing Activities-4340-13388-18121-44799
Cash Flow from Financing Activitie-42248178794239768
Net Cash Inflow / Outflow1482-371-2515945
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1917.22.
  • 3Y Stock Price CAGR of the stock is 18.0.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹13717 Million.
  • The company generated revenue of ₹81712 Million in the previous financial year.

Piramal Pharma

258.25-8   (-3%)

Investment Amount: ₹ 14050
Current Value: ₹ 25825
Performance: 83.8%
P/L: ₹ 11775
Top Gainers
SymbolChange%
3IINFOLTD33.67(20%)
PROZONER33.25(20%)
XTGLOBAL46.97(19%)
TAJGVK441.95(16%)
NILAINFRA14.35(14%)
Top Losers
SymbolChange%
TVSHLTD9301.25(-12%)
VIPCLOTHNG44.25(-7%)
AFIL79.27(-7%)
SALASAR13.29(-6%)
DPABHUSHAN1406.2(-6%)
UNIVASTU270.45(-6%)
CROMPTON375.3(-5%)
KEEPLEARN4.66(-5%)
Similar stocks

Ind-Swift

61.4

33.25

December 1 - January 1

Bajaj Healthcare

59.1

632.25

December 1 - January 1

Zota Health Care

38.4

797.1

December 1 - January 1

Lincoln Pharma

35.8

857.05

December 1 - January 1

Brooks Laboratories

32.2

183.74

December 1 - January 1

Wanbury

20

296.2

December 1 - January 1

Nectar Lifesciences

18.5

39.75

December 1 - January 1

Dishman Carbogen Amc

16.6

285.3

December 1 - January 1

Announcing Stock of the Month!

Stock of the Month
Stock of the Month